AtriCure (ATRC)
(Delayed Data from NSDQ)
$29.02 USD
+0.21 (0.73%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $29.03 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for AtriCure, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.44 | -46.47 | 50.20 | -48.16 | -35.19 |
Depreciation/Amortization & Depletion | 15.93 | 13.70 | 95.98 | 11.29 | 8.82 |
Net Change from Assets/Liabilities | -18.24 | -18.88 | -4.85 | -6.64 | -4.62 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 37.23 | 29.51 | -155.12 | 23.63 | 15.18 |
Net Cash From Operating Activities | 4.48 | -22.14 | -13.78 | -19.87 | -15.81 |
Property & Equipment | -12.00 | -16.88 | -9.75 | -5.26 | -12.14 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | -17.24 |
Investments | 63.82 | 60.89 | 33.26 | -151.74 | 27.24 |
Other Investing Activities | -30.00 | 0.00 | 0.00 | 0.80 | 0.00 |
Net Cash from Investing Activities | 21.82 | 44.01 | 23.50 | -156.20 | -2.15 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.02 | -6.16 | -5.66 | 190.09 | -5.17 |
Issuance (Repayment) of Debt | -0.99 | -0.90 | -0.82 | -0.70 | 19.87 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.06 | 0.00 | -1.17 | 0.00 | -0.33 |
Net Cash from Financing Activities | -0.03 | -7.06 | -7.64 | 189.39 | 14.37 |
Effect of Exchange Rate Changes | -0.06 | -0.36 | -0.37 | 0.14 | -0.16 |
Net Change In Cash & Equivalents | 26.21 | 14.45 | 1.71 | 13.46 | -3.75 |
Cash at Beginning of Period | 58.10 | 43.65 | 41.94 | 28.48 | 32.23 |
Cash at End of Period | 84.31 | 58.10 | 43.65 | 41.94 | 28.48 |
Diluted Net EPS | -0.66 | -1.02 | 1.09 | -1.14 | -0.94 |
Fiscal Year End for AtriCure, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -21.28 | -13.27 | -30.44 | -20.65 | -11.59 |
Depreciation/Amortization & Depletion | 9.33 | 4.74 | 15.93 | 11.46 | 7.06 |
Net Change from Assets/Liabilities | -23.24 | -23.30 | -18.24 | -17.74 | -14.78 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 21.55 | 10.82 | 37.23 | 27.39 | 18.24 |
Net Cash From Operating Activities | -13.64 | -21.02 | 4.48 | 0.45 | -1.07 |
Property & Equipment | -5.13 | -2.77 | -12.00 | -9.21 | -5.58 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 45.67 | 12.42 | 63.82 | 63.82 | 48.32 |
Other Investing Activities | 0.00 | 0.00 | -30.00 | -30.00 | -30.00 |
Net Cash from Investing Activities | 40.54 | 9.64 | 21.82 | 24.60 | 12.73 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2.89 | -6.15 | 1.02 | -1.60 | -1.98 |
Issuance (Repayment) of Debt | -1.12 | -0.85 | -0.99 | -0.73 | -0.48 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.00 | -0.86 | -0.06 | -0.06 | -0.06 |
Net Cash from Financing Activities | -5.01 | -7.86 | -0.03 | -2.39 | -2.52 |
Effect of Exchange Rate Changes | -0.17 | -0.11 | -0.06 | -0.17 | 0.00 |
Net Change In Cash & Equivalents | 21.73 | -19.34 | 26.21 | 22.50 | 9.14 |
Cash at Beginning of Period | 84.31 | 84.31 | 58.10 | 58.10 | 58.10 |
Cash at End of Period | 106.04 | 64.97 | 84.31 | 80.60 | 67.24 |
Diluted Net EPS | -0.17 | -0.28 | -0.21 | -0.20 | -0.11 |